Health IT Very Bullish 7

₹500Cr AI health hub to generate 6,000 clinical tech jobs in Telangana

Pulsus Group's ₹500 crore investment in an AI healthcare hub in Telangana will create 6,000 direct jobs in clinical research, bioinformatics, and health data analytics, accelerating digital healthcare transformation after a Supreme Court ruling cleared regulatory roadblocks.

· 4 min read ·
Share

Key Takeaways

  • Pulsus Group's ₹500 crore investment in an AI healthcare hub in Telangana will create 6,000 direct jobs in clinical research, bioinformatics, and health data analytics, accelerating digital healthcare transformation after a Supreme Court ruling cleared regulatory roadblocks.

Mentioned

Pulsus Group company Omics International company Dr. Gedela Srinubabu person Supreme Court of India organization Government of Telangana government

Key Intelligence

Key Facts

  1. 1Pulsus Group has announced a ₹500 crore ($60M) investment to expand its Ameenpur AI Healthcare and Digital Innovation Hub in Telangana.
  2. 2The project targets creation of 6,000 direct jobs and an estimated 30,000 indirect positions as operations scale.
  3. 3A Supreme Court ruling upheld the 35-acre campus' IT/ITeS Park and SEZ status, clearing regulatory hurdles that delayed the project.
  4. 4Pulsus subsidiary Omics International had generated 2,836 direct jobs by March 2022 under the India BPO Promotion Scheme, demonstrating the group's job-creation capacity.
  5. 5The hub already employs around 1,500 people and will focus on AI-driven health solutions, clinical research, bioinformatics, and digital services.
  6. 6Pulsus plans partnerships with universities, research institutions, healthcare organizations, startups, and technology firms to drive AI innovation and talent development.
Direct Healthcare Technology Jobs
6,000 New target

Post-Supreme Court clearance expansion plan

The Ameenpur project, located near Miyapur, was envisioned as a hub for technology and employment generation. Despite delays caused by legal and regulatory challenges, we remained committed to this vision.

Dr. Gedela Srinubabu CEO, Pulsus Group

Announcement of Rs 500 crore investment

Who's Affected

Pulsus Group
companyPositive
Telangana Life Sciences Ecosystem
organizationPositive
Healthcare Institutions
organizationPositive
Regulatory Environment
governmentPositive

Analysis

For healthcare IT leaders and clinical informaticists, the Supreme Court's validation of Pulsus's SEZ status marks a pivotal moment for AI-driven healthcare infrastructure in India. The ₹500 crore commitment to the Ameenpur campus promises a surge in demand for professionals who can bridge medicine and technology—clinical research associates, bioinformatics experts, and health data scientists—while offering a scalable model for future health-tech parks.

Hyderabad-based Pulsus Group has announced a ₹500 crore (approximately $60 million) investment to accelerate the expansion of its Ameenpur AI Healthcare and Digital Innovation Hub, targeting 6,000 direct jobs and an estimated 30,000 indirect positions. The investment unlocks a 35-acre campus near Miyapur in Telangana, following a recent Supreme Court ruling that upheld the project's IT/ITeS Park and Special Economic Zone (SEZ) status. This legal clarity removes years of regulatory uncertainty and enables Pulsus to fast-track development of a facility poised to become a major hub for artificial intelligence, healthcare technology, and digital services.

Pulsus Group, a medical technology and scientific publishing company, has a track record that underscores the feasibility of its ambitious targets.

The Supreme Court's intervention is critical. The Ameenpur project was conceived as a technology and employment generator but faced delays due to legal and regulatory challenges. With the SEZ status confirmed, Pulsus can now move forward with fresh capital investment, leveraging the zone's incentives—tax benefits, streamlined customs, and operational flexibility—to attract global healthcare information and research support markets. The ruling not only validates the project but also de-risks future expansions for similar public-private technology parks in India, potentially influencing investor confidence in the broader SEZ framework.

Pulsus Group, a medical technology and scientific publishing company, has a track record that underscores the feasibility of its ambitious targets. Parliamentary records cited by the company show that its subsidiary Omics International generated 2,836 direct jobs by March 2022 under the India BPO Promotion Scheme, while its Visakhapatnam operations aimed for around 6,000 jobs with 30,000 indirect livelihoods. At Ameenpur, the company reports having already created around 1,500 direct jobs, indicating that the hub is past the pilot phase and now entering a scale-up mode. The ₹500 crore infusion is expected to create demand for software engineers, AI and machine learning specialists, healthcare data scientists, bioinformatics experts, clinical research associates, and digital service professionals, strengthening Telangana's growing technology and life sciences ecosystem, particularly along the Miyapur growth corridor.

From a market perspective, the investment aligns with India's National Strategy for Artificial Intelligence and its push to become a global digital health destination. Telangana has been cultivating an IT and life sciences hub in Hyderabad, and the Ameenpur campus adds a dedicated AI healthcare vertical. The focus on AI-driven health solutions, clinical research, bioinformatics, and data analytics positions the hub to serve both domestic and international markets. By integrating academic partnerships with universities, research institutions, startups, and technology firms, Pulsus aims to create a collaborative innovation ecosystem rather than a standalone facility, potentially accelerating the translation of AI research into clinical practice.

What to Watch

The timing is opportune. Global healthcare AI spending is projected to grow rapidly, and India's talent pool and cost advantages make it a competitive location for healthcare tech outsourcing and R&D. The SEZ status offers a credible value proposition for multinational clients seeking compliant, high-quality data processing and clinical support services. However, the project must navigate execution risks—infrastructure development on a 35-acre campus, talent acquisition in a hyper-competitive AI job market, and potential future regulatory shifts. Pulsus's commitment to partnerships and its demonstrated ability to create jobs mitigate some concerns, but the long-term success will depend on its ability to integrate AI innovations with real-world healthcare outcomes and maintain policy support from state and central governments.

Looking ahead, the Ameenpur hub could become a template for AI healthcare parks in other Indian states. If successful, it will demonstrate how judicial clarity, targeted investment, and ecosystem collaboration can transform a regulatory-stalled project into a engine for employment and technological advancement. For Telangana, the campus reinforces Hyderabad's reputation as a pharmaceutical and IT powerhouse, now with a dedicated AI healthcare dimension. For the healthcare and AI industries, it signals a growing convergence where technology campuses are specifically designed to house interdisciplinary teams working on health data, algorithms, and clinical applications under one roof. The next milestones will be the pace of construction, the signing of anchor partnership agreements, and the actual hiring ramp-up, which will be closely watched by industry stakeholders.

Cite This Page

"₹500Cr AI health hub to generate 6,000 clinical tech jobs in Telangana." Healthcare Intelligence Brief, June 16, 2026. https://gethealthbrief.com/story/500cr-ai-health-hub-telangana-6000-clinical-jobs

How we covered this story

Every story in our healthcare coverage is assembled from multiple primary sources, cross-referenced for factual consistency, and scored along three independent dimensions: sentiment, operational impact, and source-cluster confidence. Single-source rumors and unverifiable claims do not pass our editorial gate. When a story shows "Verified by N sources" with N≥2, the development is independently corroborated; when N=1, we mark it explicitly so readers can weigh the signal accordingly.

Impact scoring uses a 1-10 scale weighted toward regulatory, financial, and operational consequence rather than coverage volume. A topic that runs in every outlet but moves no real decisions ranks lower than a niche regulatory filing that reshapes how operators in the healthcare space have to behave. Read our full methodology for the scoring rubric, our glossary for term definitions, and our trends index for the longitudinal view across the beat.

Sources are only linked to a story once they clear our classification pipeline at a minimum 35 percent relevance threshold. According to that methodology, reviewed July 2026, this follows multi-source corroboration standards recommended by journalism research bodies such as the Reuters Institute for the Study of Journalism.

See something wrong in this story — a wrong fact, a broken source link, a misattributed entity? Report a data issue.